Heart Disease News and Research

Latest Heart Disease News and Research

Study: 28.8% of CAD patients who fails to undergo complete revascularization face higher mortality rate

A 3-year, retrospective study by cardiologists from the Minneapolis Heart Institute Foundation and the University of Minnesota determined that 28.8% of patients with significant coronary artery disease who did not undergo complete revascularization had a higher mortality rate than patients completely revascularized.

23 Apr 2010

Study finds no decrease in access to medical care for sicker patients needing CABG surgery

New UC Davis research has found that patients scheduled to undergo coronary artery bypass graft (CABG) surgery in California were just as ill in 2003 - when public reporting of performance data for this particular surgery began - as in 2006, evidence that "report cards" did not cause doctors or hospitals to turn away sicker patients.

23 Apr 2010

Advances in understanding of cardiac-specific genes in heart development

Researchers at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) announced today the results of research which they believe marks a significant advance in understanding how cardiac-specific genes are turned on during the development of the heart in mice embryos.

23 Apr 2010

More tips to protect lungs on elevated-ozone days

It's a harmless-looking pale blue gas, a relative of the oxygen molecule that sustains life. In the upper atmosphere, a layer of it protects us from the sun's harmful rays.

23 Apr 2010

Real-people videos and expert advice to address childhood obesity

More than anything, bad habits are to blame for the childhood obesity epidemic. For Alejandra and her parents, food was an expression of love. But overeating and other unhealthy habits led this 11-year-old Hispanic girl to become an overweight kid.

23 Apr 2010

Coronary CTA can be alternative, non-invasive diagnostic imaging test to triage CAD patients: Study

Non-invasive coronary computed tomography angiography is a cost-effective alternative to invasive cardiac catheterization in the care of patients who have positive stress test results but a less than 50 percent chance of actually having significant coronary artery disease, according to a study in the May issue of the American Journal of Roentgenology.

23 Apr 2010

New blood test to determine patients at low risk for rejection of transplanted hearts

After his heart transplant in 2005, Ramon Llenado underwent a biopsy every week, then every month, then every three months. Most heart transplant patients face a lifetime of these invasive tests, which involve snipping out tiny pieces of heart to check for possible organ rejection.

23 Apr 2010

New on-off switches: SUMO protein silences developmental genes, SNP2 snips SUMO to allow gene expression

Deleting a gene in mouse embryos caused cardiac defects and early death, leading researchers to identify a mechanism that turns developmental genes off and on as an embryo matures, a team led by a scientist at The University of Texas M. D. Anderson Cancer Center reported today in Molecular Cell.

23 Apr 2010

Researchers take major step to predict adverse drug reactions using genetic information

In a new study, researchers at Mount Sinai School of Medicine have taken a major step toward the ability to predict adverse drug reactions, using genetic, cellular, and clinical information to learn why some medicines cause heart arrhythmias in patients. Published in the April 20 issue of the journal Science Signaling, the new framework described in the study could potentially be applied to the study of medications that treat other diseases and disorders such as epilepsy and autism.

23 Apr 2010

Research associates diabetes with atrial fibrillation

As the U.S. population keeps aging and gaining weight, diabetes is becoming increasingly common. Some research has associated diabetes with the most common kind of chronically irregular heartbeat, called atrial fibrillation, which can raise the risk for stroke and death. But results of past studies of diabetes and atrial fibrillation have conflicted.

23 Apr 2010

Techniques to protect organs during bypass surgery impair autoregulation, increase risk of stroke: Study

The standard practice of cooling and then rewarming a patient to prevent organ damage during cardiac bypass surgery may impair the body's mechanism that controls blood flow to the brain, potentially increasing the patient's risk of stroke, new research from Johns Hopkins suggests.

23 Apr 2010

Interesting heart rate dynamics in premature infants

A normal healthy heart beats at a variable rate with extraordinarily complex fluctuations across a wide range of time scales. Reduced complexity of heart rate has both clinical and dynamical significance - it may provide warning of impending illness, or clues about the dynamics of the heart's pacemaking system.

23 Apr 2010

Physio-Control decides to perform voluntary correction of LIFEPAK 15 monitor/defibrillators

Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today the U.S. Food and Drug Administration has classified the company's decision to perform a voluntary correction of LIFEPAK 15 monitor/defibrillators manufactured prior to December 16, 2009 as a Class I recall.

23 Apr 2010

Nicotine poisoning linked to weight gain

A new study links nicotine poisoning with weight gain, and concludes tha active smokers, not only those who stop, put on more weight than non-smokers. After four years of analysis in the University of Navarra, those who put on least weight were those who had never smoked.

23 Apr 2010

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Geron Corporation today announced five presentations by Geron scientists and collaborators on the company's telomerase inhibitor, imetelstat sodium, including the drug's activity against cancer stem cells, at the 101st American Association for Cancer Research annual meeting held in Washington D.C.

23 Apr 2010

Medical groups adopt stricter ethics code against conflicts of interest

The Associated Press: A new ethics code adopted by leading medical groups on Wednesday is supposed to keep the drug and medical device industry from having too much financial influence over medical practitioners. "It's the most sweeping move ever taken by the Council of Medical Specialty Societies to curb conflict of interest — a growing concern as private industry bankrolls a greater share of medical research.

23 Apr 2010

Hospitals striving to provide balloon angioplasties in under 60 minutes for patients undergoing heart attacks

National guidelines say patients undergoing heart attacks should receive balloon angioplasties as soon as possible or within 90 minutes of arriving at the hospital -- known as the "door-to-balloon time."

23 Apr 2010

Researchers produce stem cells from eggs of aging mice for regenerative medicine

Researchers at NYU Langone Medical Center have created stem cells from the eggs of aging mice that could be used for reproductive purposes and regenerative medicine. The study, published in April issue of Aging Cell, found that even though the eggs from older females were slightly less efficient at making stem cells than those from younger females, the capacity to create stem cells was sustained.

23 Apr 2010

Researchers to measure children with Down syndrome to develop new growth charts

Parents and doctors have known for a long time that children with Down syndrome tend to grow more slowly and are considerably shorter than most other children. But pediatricians needing to record growth milestones at regular office visits have an outdated set of growth charts based on data collected more than 25 years ago.

23 Apr 2010

Nile Therapeutics prices underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the pricing of its previously announced underwritten public offering of 6,500,000 units of its securities at a public offering price of $0.70 per unit. Each unit consists of one share of Nile common stock and 0.30 warrants to purchase common stock.

23 Apr 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Study: 28.8% of CAD patients who fails to undergo complete revascularization face higher mortality rate

Study finds no decrease in access to medical care for sicker patients needing CABG surgery

Advances in understanding of cardiac-specific genes in heart development

More tips to protect lungs on elevated-ozone days

Real-people videos and expert advice to address childhood obesity

Coronary CTA can be alternative, non-invasive diagnostic imaging test to triage CAD patients: Study

New blood test to determine patients at low risk for rejection of transplanted hearts

New on-off switches: SUMO protein silences developmental genes, SNP2 snips SUMO to allow gene expression

Researchers take major step to predict adverse drug reactions using genetic information

Research associates diabetes with atrial fibrillation

Techniques to protect organs during bypass surgery impair autoregulation, increase risk of stroke: Study

Interesting heart rate dynamics in premature infants

Physio-Control decides to perform voluntary correction of LIFEPAK 15 monitor/defibrillators

Nicotine poisoning linked to weight gain

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Medical groups adopt stricter ethics code against conflicts of interest

Hospitals striving to provide balloon angioplasties in under 60 minutes for patients undergoing heart attacks

Researchers produce stem cells from eggs of aging mice for regenerative medicine

Researchers to measure children with Down syndrome to develop new growth charts

Nile Therapeutics prices underwritten public offering of common stock

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in